CB-103

• Description:

  CB-103 is a orally active inhibitor of notch signaling pathway, with anti-tumor activity. CB-103 has shown the ability to block NOTCH signaling in human T cell acute lymphoblastic leukemia cancer cell lines, and exhibits anti-tumor efficacy in GSI resistant T-ALL cell lines.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  242.32

• Molecular Formula:

  C15H18N2O

• Notes:

  Research use only, not for human use.

• Receptor:

  Notch

• CAS Number:

  218457-67-1